Prot #HGS1006-C1124: A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated with or without BENLYSTA™ (belimumab)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/9/14 → 11/30/24

Funding

  • Outcome Sciences Inc. ((OE) Prot #HGS1006-C1124 // (OE) Prot #HGS1006-C1124)
  • GlaxoSmithKline LLC ((OE) Prot #HGS1006-C1124 // (OE) Prot #HGS1006-C1124)